We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Internal Medicine

Enhancing Venous Thromboembolism Prevention Through Patient-Centered Nurse and Patient Education in Community Hospitals

MedXY Editorial Team•Oct 9, 2025•Internal Medicine
venous thromboembolism

Highlight

  • Missed doses of pharmacologic VTE prophylaxis significantly declined following implementation of a nurse-focused and patient-centered education bundle in a community hospital setting.
  • Patient refusal rates for VTE prophylaxis decreased by nearly half, illustrating the impact of real-time patient education and nurse engagement.
  • The intervention demonstrated that evidence-based strategies developed in academic centers can be effectively deployed and sustained in community hospitals with diverse patient populations.

Study Background

Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, represents a leading cause of preventable morbidity and mortality in hospitalized patients globally. Prophylactic pharmacologic regimens markedly reduce VTE incidence; however, a substantial proportion of prescribed doses are missed due to patient refusal or logistical failures in administration. Prior research in academic hospitals has established nurse and patient education interventions to reduce missed prophylaxis doses, but their scalability to community hospitals — where most inpatient care occurs — remains uncertain. Given the burden of VTE and the potential to improve patient safety, understanding and expanding effective implementation strategies in community settings is crucial.

Study Design

This prospective cohort study was conducted at a large health system’s community hospital, spanning seven inpatient floors. It included all adult patients who were hospitalized and prescribed at least one dose of pharmacologic VTE prophylaxis between July 1, 2018, and December 31, 2019. The preintervention period covered July 1, 2018, to June 30, 2019, and the postintervention period July 1 to December 31, 2019. Interventions comprised a dynamic, scenario-based educational module targeted at nurses, coupled with a patient-centered education bundle delivered in real time. A key operational element was a live alert sent to the charge nurse whenever a prescribed VTE dose was not administered, triggering just-in-time communication with patients. The primary outcome was the proportion of missed doses of VTE prophylaxis. Secondary outcomes included categorization of missed doses into patient refusals and other reasons unrelated to refusal. Data were analyzed from January 2020 to January 2022.

Key Findings

The study enrolled 15,752 patients (55.3% female; mean age 63.9 years). During the preintervention period, 12.9% (10,643 of 82,269) of prescribed doses were missed, which dropped significantly to 9.3% (2,718 of 29,338) postintervention (odds ratio [OR], 0.60; 95% confidence interval [CI], 0.55–0.66). The reduction was driven largely by a marked decrease in patient refusals, which fell from 8.8% to 5.8% of doses (OR, 0.51; 95% CI, 0.46–0.58). Doses missed for reasons other than refusal were also reduced from 4.1% to 3.5% (OR, 0.87; 95% CI, 0.77–0.99). Notably, there was no significant difference in the incidence of VTE events between the two periods (0.08% preintervention vs 0.1% postintervention, P = .58), although event rates were very low overall.

These results highlight that engaging frontline nursing staff through comprehensive education and leveraging patient-centered communication at the time of dose administration can effectively elevate prophylaxis adherence. Importantly, the study demonstrates success in a typical community hospital environment, which often faces different logistical and cultural challenges relative to tertiary academic institutions.

Expert Commentary

This study reinforces the critical role of nurses as intermediaries in medication adherence and patient safety interventions. By equipping nurses with scenario-based knowledge and embedding real-time alerts, the study created a robust feedback loop to ensure timely administration of VTE prophylaxis.

Reducing patient refusals may hinge on personalized education, addressing patient misconceptions or discomfort that contribute to nonadherence. The lack of increase in VTE despite fewer missed doses suggests that improvements were achieved without jeopardizing patient safety.

However, the study’s observational design may be susceptible to confounding factors, such as concurrent institutional initiatives or seasonal variations affecting prophylaxis practices and VTE risk. Generalizability beyond this single community hospital warrants cautious optimism; replication in diverse settings will further validate scalability.

Additionally, the intervention’s reliance on electronic health record alerts and dedicated nurse resources introduces potential barriers in settings with limited informatics infrastructure or staffing shortages. Future research should explore cost-effectiveness and long-term sustainability.

Conclusion

Implementing a multifaceted, patient-centered education bundle targeted at frontline nurses and patients significantly reduced missed and refused doses of VTE prophylaxis across an entire community hospital. These findings illustrate that effective interventions from academic hospitals can be adapted and successfully integrated into community hospital workflows. Broad adoption could markedly enhance patient safety by ensuring that hospitalized patients receive essential thromboprophylaxis. Ongoing efforts should focus on tailoring such interventions to different healthcare contexts and evaluating their impact on clinical outcomes over longer durations.

References

Haut ER, Owodunni OP, Shaffer DL, McQuigg D, Samuel D, Hobson DB, Kraus PS, Wang J, Webster KLW, Kantsiper M, Harris JE Jr, Holzmueller CG, Varasteh Kia M, Streiff MB, Lau BD. Implementing a Patient-Centered Education Bundle to Improve Venous Thromboembolism Prevention. JAMA Surg. 2025 Oct 8. doi: 10.1001/jamasurg.2025.4136. Epub ahead of print. PMID: 41060638.

Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2_suppl):e195S-e226S.

Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):381S-453S.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Combined Oral Contraception: Evolution, Safety, and Clinical ImplicationsThis review examines the development, efficacy, and safety of combined oral contraceptives (COCs), highlighting the emergence of natural-estrogen-containing formulations and their role in optimizing contraceptive care.Sep 7, 2026High Venous Thromboembolism Incidence in Endometrial Cancer Patients Undergoing Chemotherapy: Implications for Risk Stratification and ProphylaxisOver 25% of endometrial cancer patients receiving chemotherapy develop venous thromboembolism, with advanced cancer stage as the key risk factor, highlighting the need for tailored risk assessment and preventive strategies.Sep 1, 2026Oral Anticoagulation Significantly Lowers Venous Thromboembolism Rates in Ovarian Cancer Patients on First-Line Chemotherapy: Insights from a Quality Improvement ProjectA quality improvement initiative integrating oral anticoagulants reduced venous thromboembolism incidence in ovarian cancer patients undergoing first-line chemotherapy without increasing bleeding risks.Aug 25, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Endometriosis Linked to Elevated Long-Term Risk of Venous Thromboembolism: Insights from a Nationwide Danish Cohort Study
A comprehensive Danish nationwide study reveals that women with endometriosis face a significantly increased long-term risk of venous thromboembolism, underscoring the need for heightened clinical vigilance and tailored risk management.
Aug 22, 2026
Preventing Maternal Deaths from Venous Thromboembolism: Insights from a 12-Year Nationwide French AnalysisA nationwide French study reveals that nearly half of maternal deaths due to venous thromboembolism are preventable, emphasizing the importance of ongoing risk assessment and appropriate thromboprophylaxis during pregnancy and postpartum.Aug 19, 2026
Recurrent Venous Thromboembolism After Isolated Distal DVT: Insights from the RIDTS TrialThis article reviews the incidence and predictors of recurrent VTE following anticoagulation for isolated distal deep vein thrombosis, highlighting key risk factors and implications for treatment duration and patient management.Jul 7, 2026